Copyright
©The Author(s) 2025.
World J Gastrointest Endosc. Oct 16, 2025; 17(10): 107482
Published online Oct 16, 2025. doi: 10.4253/wjge.v17.i10.107482
Published online Oct 16, 2025. doi: 10.4253/wjge.v17.i10.107482
Table 1 Main genetic alteration in pancreatic tumors
| Pancreatic tumor | Gene altered | Frequency (%) |
| PDAC | KRASTP53 | 95 |
| CDKN2A | 35-40 | |
| p16 | 95-100 | |
| SMAD4 | 45-60 | |
| IPMN | KRAS | 45-50 |
| GNAS | 35-50 | |
| P-NET | MEN1 | 10-30 |
| MCN | KRAS | 20-50 |
| GNAS | 25-50 | |
| SCA | VHL | 40-50 |
- Citation: Chien MS, Lin CC, Lai JH. How to distinguish pancreatic tumors and assess the necessity for biopsy. World J Gastrointest Endosc 2025; 17(10): 107482
- URL: https://www.wjgnet.com/1948-5190/full/v17/i10/107482.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i10.107482
